BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy
High-risk neuroblastoma (NB) represents a major clinical challenge in pediatric oncology due to relapse of metastatic, drug-resistant disease, and treatment-related toxicities. An analysis of 1235 primary NB patient dataset revealed significant increase in AKT1 and AKT2 gene expression with cancer s...
Enregistré dans:
| Auteurs principaux: | Rameswari Chilamakuri, Danielle C. Rouse, Yang Yu, Abbas S. Kabir, Aaron Muth, Jianhua Yang, Jeffery M. Lipton, Saurabh Agarwal |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2022
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/876fff3a8ac947789e0b637412ec2d83 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Neuroblastomas en el niño
par: E,BAUZA, et autres
Publié: (1950) -
PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
par: Shin Pai, et autres
Publié: (2021) -
Determination of dose enhancement caused by AuNPs with Xoft® Axxent® Electronic (eBx™) and conventional brachytherapy: in vitro study
par: Shahhoseini E, et autres
Publié: (2018) -
10 palabras clave sobre racismo y xenofobia
par: Blázquez Ruiz, F. Javier, dir
Publié: (1996) -
Neuroblastoma de Alto Risco no Uruguai. Onde estamos?
par: Fabiana Morosini, et autres
Publié: (2018)